Search Results

Displaying Results 26-28 of 28 "'IMUX'"
Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.
Immunic to Participate in Scientific and Investor Conferences in October

Oct 01, 2025, 06:30 ET Immunic to Participate in Scientific and Investor Conferences in October

Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases,

More news about: Immunic, Inc.

Immunic Presented Key Vidofludimus Calcium Data at the 41st Congress of ECTRIMS, Highlighting Its Potential in Multiple Sclerosis

Sep 25, 2025, 06:30 ET Immunic Presented Key Vidofludimus Calcium Data at the 41st Congress of ECTRIMS, Highlighting Its Potential in Multiple Sclerosis

Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases,

More news about: Immunic, Inc.

Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.